2 completed, 2 not yet recruiting. 3 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Roflumilast Oral Tablet: new trials by email Literature Review of Roflumilast Oral Tablet trials Research Report on Roflumilast Oral Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation | Phase 4 | Not yet recruiting | Sidra Aziz | 70 | 2027-02-01 | 2026-08-31 |
| A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD Hemay005 tablets, Roflumilast Oral Tablet, Placebo tablet - COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Not yet recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 120 | 2026-01-01 | 2026-01-02 |
| Roflumilast to Treat Cognitive Sequela After Stroke Roflumilast Oral Tablet - Cerebrovascular Disorders, Memory | Phase 2 | Completed | Maastricht University | 100 | 2021-07-07 | 2024-01-17 |
| Roflumilast in Non-CF Bronchiectasis Study (2019) Roflumilast Oral Tablet - Non-cystic Fibrosis Bronchiectasis | Phase 2 | Completed | The University of Hong Kong | 42 | 2020-11-12 | 2024-12-09 |
Pulmonary Disease, Chronic Obstructive (2) · Cerebrovascular Disorders (1)
Ganzhou Hemay Pharmaceutical Co., Ltd (1) · Maastricht University (1) · Sidra Aziz (1) · The University of Hong Kong (1)
China (1) · Hong Kong (1) · Netherlands (1)